Synopsis of recent research by authors named "Junlong Liang"
Junlong Liang's recent research heavily focuses on innovative therapeutic strategies for cancer treatment, specifically targeting the tumor microenvironment (TME) to enhance immunotherapy and metabolic therapy.
His studies explore the development of engineered nanoplatforms and biohybrids that disrupt cellular homeostasis, upregulate immune responses, and regulate metabolic pathways to improve therapeutic efficacy against tumors.
Findings indicate that these engineered systems can significantly enhance different forms of cancer therapy, including inducing pyropotosis, modulating lactate levels, enhancing immunogenic cell death, and stimulating the formation of tertiary lymphoid structures, showcasing their potential for combined therapies in cancer treatment.
